| Location |
Switzerland - Geneva
|
|---|---|
| Event Type | Grant & Award |
| Subject Area | Nanomedicine - Pharmaceutics |
Through grant flexibilities, countries can use up to 5% of existing Global Fund grants to fight COVID-19 and mitigate the impact the pandemic has on HIV, TB and malaria programs. Up to US$500 million is available through these grant savings and reprogramming.
Under the guidelines, the Global Fund encourages countries to redeploy underutilized assets, repurpose grant savings and reprogram funding from existing grants. Activities include, but are not limited to, epidemic preparedness assessment, laboratory testing, sample transportation, use of surveillance infrastructure, infection control in health facilities, and information campaigns.
